Back to Search Start Over

Do consumers substitute opium for hashish? An economic analysis of simultaneous cannabinoid and opiate consumption in a legal regime.

Authors :
Chandra S
Chandra M
Source :
Drug and alcohol dependence [Drug Alcohol Depend] 2015 Nov 01; Vol. 156, pp. 170-175. Date of Electronic Publication: 2015 Sep 25.
Publication Year :
2015

Abstract

Aim: To analyze interrelationships in the consumption of opiates and cannabinoids in a legal regime and, specifically, whether consumers of opiates and cannabinoids treat them as substitutes for each other.<br />Method: Econometric dynamic panel data models for opium consumption are estimated using the generalized method of moments (GMM). A unique dataset containing information about opiate (opium) consumption from the Punjab province of British India for the years 1907-1918 is analyzed (n=252) as a function of its own price, the prices of two forms of cannabis (the leaf (bhang), and the resin (charas, or hashish)), and wage income. Cross-price elasticities are examined to reveal substitution or complementarity between opium and cannabis.<br />Results: Opium is a substitute for charas (or hashish), with a cross price elasticity (βˆ3) of 0.14 (p<0.05), but not for bhang (cannabis leaves; cross price elasticity=0.00, p>0.10). Opium consumption (βˆ1=0.47 to 0.49, p<0.01) shows properties of habit persistence consistent with addiction. The consumption of opium is slightly responsive (inelastic) to changes in its own price (βˆ2=-0.34 to -0.35, p<0.05 to 0.01) and consumer wages (βˆ1=0.15, p<0.05).<br />Conclusion: Opium and hashish, a form of cannabis, are substitutes. In addition, opium consumption displays properties of habit persistence and slight price and wage income responsiveness (inelasticity) consistent with an addictive substance.<br /> (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-0046
Volume :
156
Database :
MEDLINE
Journal :
Drug and alcohol dependence
Publication Type :
Academic Journal
Accession number :
26455552
Full Text :
https://doi.org/10.1016/j.drugalcdep.2015.09.015